June 2, 2008 - Abbott has submitted an application for Seizo Hanbai Shonin (Marketing Authorization License) to Japan's Ministry of Health, Labour and Welfare (MHLW)/Pharmaceuticals and Medical Devices Agency (PMDA) to gain approval for its XIENCE V Everolimus Eluting Coronary Stent System to treat coronary artery disease.
